Clinical trial documents, patient materials, regulatory submissions, and pharmaceutical dossiers translated by Portuguese-speaking medical specialists.
Brazil is Latin America's largest pharmaceutical market and home to ANVISA, the national health surveillance authority with detailed submission requirements. Portugal operates under EMA frameworks. Our Portuguese medical translators are native speakers with medical or pharmaceutical qualifications and experience with both regulatory environments.
Translators with experience in Brazilian ANVISA submissions and Portuguese EMA/INFARMED regulatory documentation.
All Portuguese medical translations handled by translators holding degrees in medicine, pharmacy, or life sciences.
Translation, specialized medical editing, and final terminology review using validated Portuguese medical glossaries.
Patient documents and regulatory materials matched to the correct Portuguese variant for the target market.
“We are extremely satisfied with the translation services provided. The translations were accurate, professional, and delivered on time. The attention to detail and linguistic precision were outstanding. Communication was smooth, and the team was always responsive and helpful. We highly recommend their services and will definitely use them again in the future!”
Google review (INTL) , a year ago
“Amazing service! Very professional and quick. Greta communication via WhatsApp and email. I needed my documents very last minute and BeTranslated bent over back to help me with it, delivering hard copy too! Thank you - will use them definitely again in future.”
Google review (SL) , 9 months ago
“We regularly use BeTranslated's translation services and are very satisfied with their work. The team is professional and highly efficient! We highly recommend them.”
Google review (FR) , 2 years ago
Yes. Our Brazilian Portuguese medical translators are familiar with ANVISA technical documentation requirements and the specific formatting conventions for drug registration dossiers.
Yes. We can produce two parallel versions in the same project, one in European Portuguese and one in Brazilian Portuguese, with consistent medical terminology throughout.
We create a project-specific glossary and enforce it consistently using CAT tools and translation memories across all documents in the dossier.
In addition to ANVISA (Brazil) and INFARMED (Portugal), we work with Angola's ARMED (Agencia Reguladora de Medicamentos e Tecnologias de Saude), Mozambique's DNAM (Direccao Nacional de Assistencia Medica) regulatory submissions, and Cape Verde's health authority filings. For multi-country Lusophone Africa submissions we run a single source pass and adapt terminology to each national authority's conventions in parallel.
Every translator and project manager signs a GDPR-aligned data processing agreement before receiving any patient-identifiable or trial-confidential material. Files are transferred over encrypted channels, processed on secure infrastructure, and purged from our systems on project closure unless you request translation memory retention. For Brazil-originating projects we apply LGPD (Lei Geral de Protecao de Dados) aligned data handling on top of EU GDPR standard protocols.
Related Services
Send us your portuguese medical translation files, language pairs, and deadline. We will confirm specialist availability, certification needs, and a clear quote as quickly as possible.
